ADME-Toxicology Testing Global Market Report 2022: Growth Momentum Shifts Away from In Vivo Technologies as In Vitro Technologies Lead the Charge – QNT Press Release


DUBLIN, Oct. 26, 2022 /PRNewswire/ — The “ADME-Toxicology Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027

In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$12.3 Billion by 2027, growing at a CAGR of 10.9% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 13.4% CAGR and reach US$5.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the High Throughput Screening segment is readjusted to a revised 7.6% CAGR for the next 7-year period.

The US Market is Estimated at $3 BillionWhile China is Forecast to Grow at 15.4% CAGR

The ADME-Toxicology Testing market in the US is estimated at US$3 Billion in the year 2020. Chinathe world’s second largest economy, is forecast to reach a projected market size of US$966.9 Million by the year 2027 trailing a CAGR of 15.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canadaeach forecast to grow …

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center